WHO approves resolution on treating hepatitis

The World Health Assembly has approved a resolution to improve the prevention, diagnosis and treatment of viral hepatitis, as well as placing proposals to improve global coordination in addressing non-communicable diseases (NCD).

A press release from the World Health Organisation’s Regional Office for Southeast Asia, dated May 22, read that the resolution also highlighted the importance of expanding hepatitis A and B vaccination programmes and further strengthening infection control measures in health care settings – such as strategies to improve the safety of injections. 

The resolution noted the importance of implementing appropriate measures to protect groups, such as people who inject drugs, from infection and to improve their access to diagnostics and treatment.

Delegates agreed to consider a range of measures to improve access to quality and affordable hepatitis medicines and diagnostics, while addressing intellectual property rights issues related to those products.

The delegates asked the WHO Secretariat to continue to help countries develop robust strategies and goals on hepatitis and to report regularly on the progress of such programmes, as well as examining the feasibility of eliminating hepatitis B and C.

Hepatitis is responsible for 1.4 million deaths every year, while 500 million people currently live with the disease.

The delegates further approved nine indicators to measure progress in implementing the WHO Global NCD Action Plan.

The assembly recommended that the WHO director general submit proposed terms of reference for a United Nations Interagency Task Force on NCDs to the United Nations Economic and Social Council (Ecosoc).